ICD-10 Code B55.2 | Mucocutaneous leishmaniasis Symptoms, Diagnosis, Billing

Mucocutaneous leishmaniasis is a severe form of leishmaniasis caused by the protozoan parasites of the Leishmania genus. It primarily affects the mucous membranes and skin, leading to significant morbidity. Accurate coding with ICD-10 Code B55.2 is essential for proper diagnosis, documentation, medical billing, and public health reporting, ensuring that healthcare providers can effectively manage and treat this condition.

What is ICD-10 Code B55.2 for Mucocutaneous leishmaniasis?

ICD-10 Code B55.2 specifically denotes Mucocutaneous leishmaniasis, a condition characterized by lesions affecting the mucous membranes and skin due to Leishmania infection. This code should be utilized in clinical documentation and billing when diagnosing patients with this condition, ensuring accurate representation of the disease and facilitating appropriate treatment and resource allocation.

ICD-10 Code B55.2 – Clinical Definition and Explanation of Mucocutaneous leishmaniasis

Mucocutaneous leishmaniasis is caused by the Leishmania braziliensis species and is transmitted through the bite of infected sandflies. The condition can progress from cutaneous leishmaniasis and requires prompt medical attention to prevent complications such as disfigurement and secondary infections.

Key Clinical Features:

• Presence of ulcerative lesions on mucous membranes, particularly in the nose and mouth.
• Potential for secondary bacterial infections due to skin breakdown.
• History of travel to endemic areas where leishmaniasis is prevalent.
• Symptoms may include nasal obstruction, epistaxis, and oral lesions.

ICD-10 Code B55.2 for Mucocutaneous leishmaniasis – SOAP Notes & Clinical Use

In SOAP notes, ICD-10 Code B55.2 is utilized to document the diagnosis of Mucocutaneous leishmaniasis, capturing the patient's symptoms, assessment findings, and treatment plans. This code is relevant in both acute and chronic care settings, ensuring comprehensive patient management.

What Does ICD-10 Code B55.2 for Mucocutaneous leishmaniasis Mean in SOAP Notes?

ICD-10 Code B55.2 connects subjective patient-reported symptoms and objective clinical findings to a formal diagnosis of Mucocutaneous leishmaniasis. This code is crucial for ensuring continuity of care, supporting accurate billing, and meeting EHR documentation standards.

Treatment Options for ICD-10 Code B55.2 – Mucocutaneous leishmaniasis

Mucocutaneous leishmaniasis requires prompt treatment to prevent severe complications. Hospitalization may be necessary for severe cases, and treatment typically involves specific antileishmanial therapies.

Antibiotic Therapy:

• First-line treatment includes pentavalent antimonials (e.g., sodium stibogluconate) for 20-30 days.
• Alternative options may include amphotericin B for severe cases.
• Miltefosine is also an oral option for treatment.

Supportive Care:

• Wound care to manage lesions and prevent secondary infections.
• Pain management and nutritional support as needed.
• Psychosocial support for patients experiencing disfigurement.

Infection Control:

• Implement vector control measures to prevent sandfly bites.
• Educate patients on avoiding endemic areas during peak transmission seasons.
• Use insect repellent and protective clothing in endemic regions.

How to Document Symptoms of Mucocutaneous leishmaniasis (ICD-10 B55.2) in SOAP Notes

Subjective:

• Patient reports painful lesions in the nasal cavity and mouth.
• History of travel to endemic areas within the last six months.
• Complaints of nasal obstruction and occasional bleeding.
• Patient expresses concern about the appearance of lesions.

Objective:

• Ulcerative lesions observed on the nasal mucosa and oral cavity.
• Vital signs stable; no fever noted.
• Swelling and erythema surrounding the lesions.
• No signs of systemic infection at this time.

Secure, compliant, and built for trust

HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.

Learn more

SOAP Note Guidelines for Diagnosing Mucocutaneous leishmaniasis (ICD-10 Code B55.2)

Assessment:

• Diagnosis: Mucocutaneous leishmaniasis, moderate severity.
• ICD-10 Code: B55.2.
• Contributing factors include recent travel to endemic regions.
• Patient exhibits significant mucosal involvement.

Plan:

• Initiate treatment with pentavalent antimonials for 20-30 days.
• Educate patient on wound care and signs of secondary infection.
• Schedule follow-up appointment in two weeks to monitor treatment response.
• Consider referral to infectious disease specialist if no improvement.

Treatment & Plan Section for ICD-10 Code B55.2 – Mucocutaneous leishmaniasis

• First-line pharmacologic treatment includes pentavalent antimonials.
• Non-pharmacologic strategies involve patient education on wound care.
• Monitoring includes regular follow-up to assess treatment efficacy.
• Consider psychological support for patients with disfigurement.

Using ICD-10 Code B55.2 for Mucocutaneous leishmaniasis in Billing & SOAP Note Compliance

• Select appropriate ICD-10 code based on clinical findings and severity.
• Document symptoms clearly under Subjective (S) and Objective (O) in SOAP notes.
• Ensure treatment plans align with clinical guidelines to support justified billing.
• Include relevant CPT codes that correspond with the services provided.

Related ICD-10 Codes Often Used with Mucocutaneous leishmaniasis

• B55.0 – Cutaneous leishmaniasis
• B55.1 – Visceral leishmaniasis

ICD-10 Code B55.2 in Medical Billing and Insurance for Mucocutaneous leishmaniasis

ICD-10 Code B55.2 is critical in medical billing, particularly in hospital, ER, or infectious disease care settings.

Billing Notes:

• Ensure accurate documentation of patient history and clinical findings to support the ICD-10 claim.
• Use this code in conjunction with appropriate CPT codes for billing related services.
• Document all relevant symptoms and treatment plans to justify the use of this code.

Common CPT Pairings: